Article Information
History
- February 12, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- NA Lemmermann1,2,#,$,
- B Lieb3,#,
- T Laufs3,
- A Renzaho2,
- S Runkel1,4,
- W Kohnen1,5,
- M Linke1,6,
- S Gerber1,6,
- S Schweiger1,6,
- A Michel1,7,
- S-E Bikar1,3,*,
- B Plachter1,2,*,$ and
- T Hankeln1,8,*
- 1SARS-CoV-2 Sequencing Consortium Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
- 2Institute for Virology and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
- 3StarSEQ GmbH, Mainz, Germany
- 4Transfusion Unit & Test Center, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
- 5Department of Hygiene and Infection Prevention, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
- 6Institute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
- 7Medical Management Department, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
- 8Faculty of Biology, Institute of Organismal and Molecular Evolution, Molecular Genetics & Genome Analysis, Johannes Gutenberg University Mainz, Mainz, Germany
- ↵$correspondence to NL: lemmermann{at}uni-mainz.de, Niels A. Lemmermann, University Medical Center Mainz, Institute for Virology, Obere Zahlbacher Str. 67, 55131 Mainz, Germany
↵# equal contribution
Posted February 12, 2021.
SARS-CoV-2 genome surveillance in Mainz, Germany, reveals convergent origin of the N501Y spike mutation in a hospital setting
